Who invested in Second Genome?
Second Genome's investors include Morgenthaler Ventures and Advanced Technology Ventures.
United States · Series B startup
3 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$19Mraised across 3 rounds since 2011, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by pevc.dowjones.com
No investor was named in the report.
Reported by sec.govSEC filing: $5.0M sold, first sale Jul 2011
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Second Genome's investors include Morgenthaler Ventures and Advanced Technology Ventures.
Second Genome has raised $19M across 3 rounds since 2011.
Second Genome's most recent round was a Series B of $12M in Jun 2013.
Its most recent round, $12M in Jun 2013, is also its largest on record.
Second Genome's first round on record, in Apr 2012, was backed by Morgenthaler Ventures and Advanced Technology Ventures.
Second Genome's latest named round is a Series B, in Jun 2013.
Second Genome is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.